Medical Device Integration
Remote Monitoring and Notification
Analytics and Reports
Your Partner in Health
Solutions to Support COVID-19 Efforts
Masimo supports surge capacity efforts with a range of noninvasive monitoring and ancillary single-use solutions that can help care teams prepare for and manage an influx of patients quickly and efficiently.
Rapidly respond to an increase in patient volume:
Masimo supplies a range of advanced home monitoring solutions that help ensure you can monitor with confidence from a distance, including:
Innovative solutions help care teams minimize transmission risks and increase clinician and patient safety:
Convert to single-patient-use sensors, available in a variety of tetherless and tethered styles.
In response to blood shortages due to COVID-19, Masimo is offering licenses for rainbow® noninvasive blood constituent monitoring, including total hemoglobin, SpHb®, at no additional charge during the coronavirus pandemic:
Advanced Masimo measurements support the implementation of CDC and WHO protocols for fast screening, comprehensive triage, and quality continuous monitoring.1,2
Continuous Body Temperature
Respiration Rate from the Pleth
Noninvasive Blood Pressure
Pleth Variability Index
Masimo offers multiple respiration rate monitoring technologies, alongside a variety of spot-check and continuous monitors designed for use with single-patient-use products:
Respiration rate from the Pleth (RRp)
Acoustic Respiration Rate (RRa®)
NomoLine® Capnography (RRc™)
Product Information Sheet
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim Guidance 28 January 2020.
Centers for Disease Control and Prevention. Human Infection with 2019 Novel Coronavirus Person Under Investigation (PUI) and Case Report Form. Approved: OMB: 0920-1011.
*The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium. **Data on file. See masimo.com/sphb-outcomes for more information.
Clinical decisions regarding red blood cell transfusions should be based on the clinician’s judgment considering among other factors: patient condition, continuous SpHb monitoring, and laboratory diagnostic tests using blood samples. SpHb monitoring is not intended to replace laboratory blood testing.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.
Submit a request to receive more information and a Masimo representative will contact you shortly.